ArticleCardiovascular and interventional radiology2026
Feasibility of Spectral Computed Tomography Color Overlay to Augment Tumor Visibility for Renal Cryoablation.
Article in Cardiovascular and interventional radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aims to assess a spectral computed tomography (CT) color overlay technique for augmenting the visualization of endophytic renal tumors during percutaneous thermal ablation procedures.
methodsThis retrospective study consisted of renal cryoablation procedures from June to December 2023. Of the 68 renal ablations with spectral results archived, 27 cases were assigned majority endophytic. Two radiologists reviewed and rated two series for each case: a conventional non-contrast CT series and an electron density color overlay series. Tumor conspicuity was evaluated on a continuous sliding scale. Subsequently, radiologists determined whether percutaneous ablation could proceed based on visualization using the conventional non-contrast CT series alone, using the color overlay series, or if additional contrast-enhanced CT was necessary for optimal guidance. Statistical assessment was performed using a two-sided Wilcoxon signed-rank test with a significance level of p = 0.01.
resultsThere was a significant (p < 0.001) improvement in endophytic tumor conspicuity with the electron density fusion series (Median: 36.3) compared to the conventional CT series (Median: 19.2). When evaluating adequacy of tumor visualization for procedural planning, readers were more likely to agree when reviewing the electron density color overlay series (44% of reads; 22/50) rather than the conventional CT series (22% of reads; 11/50).
conclusionSpectral CT color overlay improved visibility of endophytic renal tumors compared to conventional CT alone. This highlights the benefit of a low-noise, narrow-window color overlay for augmenting lesion localization. LEVEL OF EVIDENCE 3: Level 3, retrospective study.
Indexed as
Identifiers
41820687What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.